immatics biotechnologies GmbH
ANTI-WT1/HLA-SPECIFIC ANTIBODIES
Last updated:
Abstract:
The present invention relates to antibodies or fragments thereof binding to human WT1/HLA. In particular, the present invention relates to antibodies or fragments thereof that have combined improved and/or beneficial properties, and are therefore suited for clinical development.
Status:
Application
Type:
Utility
Filling date:
13 Oct 2020
Issue date:
28 Jan 2021